▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #969 by analyst upside · 2026-11-12
TLRY
Tilray Brands, Inc.
Healthcare · Market Cap $386M · P/E 0x
ANALYST PRICE TARGET
+119.2%
implied upside to consensus target
Current Price $2.61
Consensus Target $5.72
Bull Target $13.0
Bear Target $4.0
Analysts Covering 9
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
3
Hold
6
Sell
0
52-Week Low $2.49
52-Week High $15.7
YTD Return -73.1%
FUNDAMENTALS
Market Cap $386M
P/E Ratio (TTM) N/A
Forward P/E 18.4x
EPS (TTM) $-1.41
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $963M
Profit Margin -17.1%
52-WEEK RANGE
52-Week Low $2.49
52-Week High $15.7
Current Price $2.61
Bear Target $4.0
Bull Target $13.0
● Now $2.61 ● Target $5.72
TRADING DATA
Avg Volume 4.1M
YTD Return -73.1%
Analyst Count 9
Consensus Hold
Upside to Target +119.2%
Last Updated 2026-11-12

ANALYST SUMMARY

Tilray Brands, Inc. (TLRY) is currently trading at $2.61 with a Wall Street consensus price target of $5.72, implying potential upside of 119.2% over the next 12 months. 9 analysts currently cover TLRY, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $13.0, while the most cautious has a target of $4.0.

TLRY operates in the Healthcare sector with a market capitalisation of $386M. The stock is down 73.1% year-to-date and is currently trading near the lower end of its 52-week range of $2.49 – $15.7.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TLRY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Hold → Hold 2026-10-09 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-07-14 Building track record
Roth Capital ↑ Upgrade
Neutral → Buy 2026-04-02 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-03-30 Building track record
Roth Capital - Reiterated
Neutral → Neutral 2026-01-20 Building track record
Jefferies - Reiterated
Buy → Buy 2025-08-25 50% win rate (6 calls)
Zelman & Assoc reit
Neutral → Neutral 2025-07-29 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2025-04-09 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
20
out of 100
Coverage depth
18/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →